-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2017 to Q1 2024.
- Autolus Therapeutics plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$40.5M, a 4.49% increase year-over-year.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$146M, a 29.6% decline from 2022.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$112M, a 4.71% increase from 2021.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$118M, a 0.09% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)